Epidemiological and Histopathological Characteristics of Renal Cell Carcinoma in Somalia

References

• Inamura K. Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification. Int J Mol Sci. 2017;18(10):15–20. doi:10.3390/ijms18102195
   Web of Science ®Google Scholar
• Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras. 2015;48(3):166–174. doi:10.1590/0100-3984.2013.1927
   PubMedGoogle Scholar
• Mahasin SZ, Aloudah N, Al-Surimi K, Alkhateeb S. Epidemiology profile of renal cell carcinoma: a 10-year patients’ experience at King Abdulaziz Medical City, National Guard Health Affairs, Saudi Arabia. Urol Ann. 2018;10(1):59–64. doi:10.4103/UA.UA_102_17
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Bergman M, Scherman-Plogell AH, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register. Scand J Urol. 2014;48(3):231–238. doi:10.3109/21681805.2013.864698
   PubMed Web of Science ®Google Scholar
• Hötker AM, Karlo CA, Di Paolo PL, et al. Renal cell carcinoma: associations between tumor imaging features and epidemiological risk factors. Eur J Radiol. 2020;129:109096. doi:10.1016/j.ejrad.2020.109096
   PubMed Web of Science ®Google Scholar
• Tahbaz R, Schmid M, Merseburger AS. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol. 2018;28(1):62–79. doi:10.1097/MOU.0000000000000454
   PubMed Web of Science ®Google Scholar
• Taneja SS. Re: large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma. J Urol. 2012;187(6):2022–2023. doi:10.1016/j.juro.2012.02.2546
   PubMed Web of Science ®Google Scholar
• Andreiana BC, Stepan AE, Mărgăritescu C, et al. Histopathological prognostic factors in clear cell renal cell carcinoma. Curr Heal Sci J. 2018;44(3):201–205.
   PubMedGoogle Scholar
• Rossi SH, Prezzi D, Kelly-Morland C, Goh V. Imaging for the diagnosis and response assessment of renal tumours. World J Urol. 2018;36(12):1927–1942. doi:10.1007/s00345-018-2342-3
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387. doi:10.1016/j.ejca.2018.07.005
   PubMed Web of Science ®Google Scholar
• Tahtabasi M, Mohamud Abdullahi I, Kalayci M, Gedi Ibrahim I, Er S. Cancer incidence and distribution at a Tertiary Care Hospital in Somalia from 2017 to 2020: an initial report of 1306 cases. Cancer Manag Res. 2020;12:8599–8611. doi:10.2147/CMAR.S277202
   PubMed Web of Science ®Google Scholar
• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79–87. doi:10.14740/wjon1279
   PubMedGoogle Scholar
• Cassell A, Jalloh M, Yunusa B, et al. Management of renal cell carcinoma — current practice in Sub-Saharan Africa. J Kidney Cancer VHL. 2019;6(4):1–9. doi:10.15586/jkcvhl.2019.122
   PubMed Web of Science ®Google Scholar
• Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma [figure presented]. Eur Urol. 2019;75(1):74–84. doi:10.1016/j.eururo.2018.08.036
   PubMed Web of Science ®Google Scholar
• van der Beek JN, Hol JA, Coulomb-l’Hermine A, et al. Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: a report of the SIOP-Renal Tumor Study Group. Int J Cancer. 2021;148(11):2724–2735. doi:10.1002/ijc.33476
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924. doi:10.1016/j.eururo.2015.01.005
   PubMed Web of Science ®Google Scholar
• Avakoudjo D, Hounnasso PP, Traore MT, et al. Experience with managing solid kidney tumours in Cotonou, Benin Republic. J West African Coll Surg. 2014;4;4:100–111.
   PubMedGoogle Scholar
• Salako AA, Badmus TA, Badmos KB, David RA, Laoye A, Akinbola IA. Renal cell carcinoma in a semi-urban population of south-western Nigeria. East Afr Med J. 2017;94(1):37–43.
   Google Scholar
• Muhammed A, Tijjani L, Yusuf M, Abdullahi S, Ahmad B, Almustapha L. Pathologic characteristics and management of renal cell carcinoma in Zaria, Nigeria. Sub-Saharan African J Med. 2015;2(1):1. doi:10.4103/2384-5147.151559
   Google Scholar
• Mayrhofer K, Niedersüß-Beke D. Evidence-based follow-up in renal cell carcinoma. Mag Eur Med Oncol. 2020;13(1):78–83.
   Google Scholar
• Fall B, Diao B, Sow Y, et al. Le cancer du rein de l’adulte au Sénégal: aspects épidémiologiques et cliniques actuels et évolution du profil sur les deux dernières décennies. [Adult renal cancer in Senegal: Current epidemiological, clinical features,profile’s evolution over the two past decades]. Prog En Urol. 2011;21(8):521–526. French. doi:10.1016/j.purol.2011.02.013
   PubMed Web of Science ®Google Scholar
• Zequi SDC, Mourão TC, De Oliveira MM, et al. Predictors of survival outcomes in non-metastatic renal cell carcinoma in Latin America and Spain: a multicentric analysis. Kidney Cancer. 2019;3(4):253–261. doi:10.3233/KCA-190068
   Google Scholar
• De RS, Sylvanus CHU. Le cancer du rein de l’adulte au Togo: frequence, diagnostic, traitement et evolution renal carcinoma of adult in Togo: frequency, diagnosis, therapeutic and evolutionary aspects. Revue Africaine d’Urologie Et d’Andrologie. 2015;1:177–182.
   Google Scholar
• Tijani KH, Anunobi CC, Ezenwa EV, et al. Adult renal cell carcinoma in Lagos: experience and challenges at the Lagos University Teaching Hospital. African J Urol. 2012;18(1):20–23. doi:10.1016/j.afju.2012.04.005
   Google Scholar
• Mbaeri TU, Orakwe JC, Nwofor AM, Oranusi CK, Ulebe AO. Malignant renal tumours in adults in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. Niger J Med. 2012;21(3):300–303.
   PubMedGoogle Scholar
• Pal DK, Maurya AK, Jana D. Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: a retrospective single-center study. Indian J Cancer. 2018;55(3):297. doi:10.4103/ijc.IJC_636_17
   PubMed Web of Science ®Google Scholar
• Douglas B, Davaro F, May A, Siddiqui S, Hamilton Z. Clinical characteristics of renal cell carcinoma in patients under the age of 40. Urol Oncol. 2021;39(7):438–e23. doi:10.1016/j.urolonc.2021.04.008
   Web of Science ®Google Scholar
• Sierra PS, Cordeiro MD, Albuquerque EV, et al. Oncologic outcomes in young adults with kidney cancer treated during the targeted therapy era. Clin Genitourin Cancer. 2020;18(2):e134–e144. doi:10.1016/j.clgc.2019.09.012
   PubMed Web of Science ®Google Scholar
• Coulibaly M, Sissoko I, Berthé A, et al. Management of kidney cancers in urology department of the Gabriel Toure University Hospital/Bamako. Surg Sci. 2018;9(6):183–188. doi:10.4236/ss.2018.9621
   Google Scholar